AstraZeneca unveils drug to treat mutating breast cancer before growth
Pharma group estimates Camizestrant could be worth up to $5bn of sales in its peak year
Info Econômico – Seu Portal de Notícias Econômicas
Fonte AstraZeneca unveils drug to treat mutating breast cancer before growth
Procurando um novo nome de domínio? Experimente a pesquisa por nomes.